Biomedical Engineering Reference
In-Depth Information
Fan J-Q, Valenzano K, Lee G, Bouvier M (2009) Pharmacological chaperones for treating obesity.
US Patent application number 20090312345 (2009)
Feder ME, Hofmann GE (1999) Heat-shock proteins, molecular chaperones, and the stress
response: evolutionary and ecological physiology. Annu Rev Physiol 61:243-282
Fuchs S, Amiel J, Claudel S et al (2001) Functional characterization of three mutations of the
endothelin B receptor gene in patients with Hirschsprung's disease: evidence for selective loss
of Gi coupling. Mol Med 7:115-124
Fujiwara TM, Bichet DG (2005) Molecular biology of hereditary diabetes insipidus. J Am Soc
Nephrol 16:2836-2846
Gebbink MFBG, Bouma B (2010) Methods of binding of cross-beta structures by chaperones. US
patent 20100015126
Gekko K, Timasheff SN (1981) Mechanism of protein stabilization by glycerol: preferential hydra-
tion in glycerol-water mixtures. Biochemistry 20:4667-4676
Gorbatyuk MS, Knox T, LaVail MM et al (2010) Restoration of visual function in P23H rhodopsin
transgenic rats by gene delivery of BiP/Grp78. Proc Natl Acad Sci U S A 107:5961-5966
Granell S, Mohammad S, Ramanagoudr-Bhojappa R et al (2010) Obesity-linked variants of mel-
anocortin-4 receptor are misfolded in the endoplasmic reticulum and can be rescued to the cell
surface by a chemical chaperone. Mol Endocrinol 24:1805-1821
Gromoll J, Schulz A, Borta H et al (2002) Homozygous mutation within the conserved Ala-Phe-
Asn-Glu-Thr motif of exon 7 of the LH receptor causes male pseudohermaphroditism. Eur J
Endocrinol 147:597-608
Hammarstrom P, Wiseman RL, Powers ET et al (2003) Prevention of transthyretin amyloid disease
by changing protein misfolding energetics. Science 299:713-716
Hartl FU, Hayer-Hartl M (2002) Molecular chaperones in the cytosol: from nascent chain to folded
protein. Science 295:1852-1858
Hartl FU, Hayer-Hartl M (2009) Converging concepts of protein folding in vitro and in vivo. Nat
Struct Mol Biol 16:574-581
Hartl FU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteo-
stasis. Nature 475:324-332
Hawtin SR (2006) Pharmacological chaperone activity of SR49059 to functionally recover
misfolded mutations of the vasopressin V1a receptor. J Biol Chem 281:14604-14614
Heding A, Vrecl M, Bogerd J et al (1998) Gonadotropin-releasing hormone receptors with intracellular
carboxyl-terminal tails undergo acute desensitization of total inositol phosphate production and
exhibit accelerated internalization kinetics. J Biol Chem 273:11472-11477
Helenius A, Trombetta E, Hebert D, Simons JF (1997) Calnexin, calreticulin and the folding
glycoproteins. Trends Biochem Sci 7:193-200
Hermosilla R, Oueslati M, Donalies U et al (2004) Disease-causing V(2) vasopressin receptors are
retained in different compartments of the early secretory pathway. Traffic 5:993-1005
Huang Y, Breitwieser GE (2007) Rescue of calcium-sensing receptor mutants by allosteric modulators
reveals a conformational checkpoint in receptor biogenesis. J Biol Chem 282:9517-9525
Hutt DM, Powers ET, Balch WE (2009) The proteostasis boundary in misfolding diseases of membrane
traffic. FEBS Lett 583:2639-2646
Ishii S, Yoshioka H, Mannen K et al (2004) Transgenic mouse expressing human mutant alpha-
galactosidase A in an endogenous enzyme deficient background: a biochemical animal model
for studying active-site specific chaperone therapy for Fabry disease. Biochim Biophys Acta
1690:250-257
Ishii S, Chang HH, Kawasaki K et al (2007) Mutant alpha-galactosidase A enzymes identified in
Fabry disease patients with residual enzyme activity: biochemical characterization and restora-
tion of normal intracellular processing by 1-deoxygalactonojirimycin. Biochem J 406:285-295
Janovick JA, Conn PM (2010) Salt bridge integrates GPCR activation with protein trafficking.
Proc Natl Acad Sci U S A 107:4454-4458
Janovick JA, Maya-Nunez G, Conn PM (2002) Rescue of hypogonadotropic hypogonadism-
causing and manufactured GnRH receptor mutants by a specific protein-folding template:
Search WWH ::
Custom Search